Continuim Equity Partners Closes Oversubscribed Fund III at $548 Million – Bringing AUM to Over $1 Billion

PITTSBURGH, Aug. 06, 2026 (GLOBE NEWSWIRE) — Continuim Equity Partners, LP (“Continuim” or the “Firm”), a Pittsburgh-based private equity firm focused on acquiring and accelerating the growth of manufacturing and industrial businesses, is pleased to announce the close of Continuim Equity Partners Fund III, LP (together with its parallel investment vehicles, “Fund III”) with $548 million in total commitments. Fund III was significantly oversubscribed and closed after 32 days in market – bringing the Firm’s assets under management to over $1 billion.

Global Regenerative Medicine Market is Projected to Cross the USD 160 Billion Mark by 2034 | DelveInsight

The regenerative medicine market is witnessing robust growth, driven by advances in stem cell therapies, gene editing, tissue engineering, and biomaterials. Rising prevalence of chronic diseases, musculoskeletal disorders, and organ failure is increasing demand for therapies that restore or replace damaged tissues rather than simply manage symptoms. Continued investment in research and development, expanding clinical pipelines, and supportive regulatory initiatives are accelerating innovation and commercialization. As more regenerative therapies gain regulatory approvals and manufacturing capabilities improve, the market is expected to experience sustained expansion over the coming years.

The regenerative medicine market is witnessing robust growth, driven by advances in stem cell therapies, gene editing, tissue engineering, and biomaterials. Rising prevalence of chronic diseases, musculoskeletal disorders, and organ failure is increasing demand for therapies that restore or replace damaged tissues rather than simply manage symptoms. Continued investment in research and development, expanding clinical pipelines, and supportive regulatory initiatives are accelerating innovation and commercialization. As more regenerative therapies gain regulatory approvals and manufacturing capabilities improve, the market is expected to experience sustained expansion over the coming years.